Xiaoming Yin1, Ravi Sachidanandam, Syed Morshed, Rauf Latif, Ruijin Shi, Terry F Davies. 1. Thyroid Research Unit (X.Y., S.M., R.L., T.F.D.), Department of Medicine, and Departments of Oncological Science (R.Sa.) and Pathology (R.Sh.), Icahn School of Medicine at Mt Sinai and the James J. Peters Veterans Affairs Medical Center, New York, New York 10468.
Abstract
CONTEXT: The immune response in autoimmune thyroid disease has been shown to occur primarily within the thyroid gland in which the most abundant antigens can be found. A variety of capture molecules are known to be expressed by thyroid epithelial cells and serve to attract and help retain an intrathyroidal immune infiltrate. OBJECTIVE: To explore the entire repertoire of expressed genes in human thyroid tissue, we have deep sequenced the transcriptome (referred to as mRNA-Seq). DESIGN AND PATIENTS: We applied mRNA-Seq to thyroid tissue from nine patients with Graves' disease subjected to total thyroidectomy and compared the data with 12 samples of normal thyroid tissue obtained from patients having a thyroid nodule removed. The expression for each gene was calculated from the sequencing data by taking the median of the coverage across the length of the gene. The expression levels were quantile normalized and a gene signature was derived from these. RESULTS: On comparison of expression levels in tissues derived from Graves' patients and controls, there was clear evidence for overexpression of the antigen presentation pathway consisting of HLA and associated genes. We also found a robust disease signature and discovered active innate and adaptive immune signaling networks. CONCLUSIONS: These data reveal an active immune defense system in Graves' disease, which involves novel molecular mechanisms in its pathogenesis and development.
CONTEXT: The immune response in autoimmune thyroid disease has been shown to occur primarily within the thyroid gland in which the most abundant antigens can be found. A variety of capture molecules are known to be expressed by thyroid epithelial cells and serve to attract and help retain an intrathyroidal immune infiltrate. OBJECTIVE: To explore the entire repertoire of expressed genes in human thyroid tissue, we have deep sequenced the transcriptome (referred to as mRNA-Seq). DESIGN AND PATIENTS: We applied mRNA-Seq to thyroid tissue from nine patients with Graves' disease subjected to total thyroidectomy and compared the data with 12 samples of normal thyroid tissue obtained from patients having a thyroid nodule removed. The expression for each gene was calculated from the sequencing data by taking the median of the coverage across the length of the gene. The expression levels were quantile normalized and a gene signature was derived from these. RESULTS: On comparison of expression levels in tissues derived from Graves' patients and controls, there was clear evidence for overexpression of the antigen presentation pathway consisting of HLA and associated genes. We also found a robust disease signature and discovered active innate and adaptive immune signaling networks. CONCLUSIONS: These data reveal an active immune defense system in Graves' disease, which involves novel molecular mechanisms in its pathogenesis and development.
Authors: R Bruno; P Giannasio; G Ronga; E Baudin; J P Travagli; D Russo; S Filetti; M Schlumberger Journal: J Endocrinol Invest Date: 2004-12 Impact factor: 4.256
Authors: Andrea P Martin; Tatjana Marinkovic; Claudia Canasto-Chibuque; Rauf Latif; Jay C Unkeless; Terry F Davies; Yousuke Takahama; Glaucia C Furtado; Sergio A Lira Journal: J Immunol Date: 2009-08-12 Impact factor: 5.422
Authors: Laura Claire Lane; Aleksander Kuś; Tomasz Bednarczuk; Artur Bossowski; Jacek Daroszewski; Beata Jurecka-Lubieniecka; Heather Jane Cordell; Simon Henry Schofield Pearce; Timothy Cheetham; Anna Louise Mitchell Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958
Authors: Ana Marín-Sánchez; Daniel Álvarez-Sierra; Oscar González; Ana Lucas-Martin; Alicia Sellés-Sánchez; Francesc Rudilla; Emma Enrich; Roger Colobran; Ricardo Pujol-Borrell Journal: Front Immunol Date: 2019-07-18 Impact factor: 7.561